Intellia Therapeutics, Inc. (NTLA)
12.26
+0.14
(+1.16%)
USD |
NASDAQ |
Oct 02, 16:00
12.16
-0.10
(-0.82%)
After-Hours: 20:00
Intellia Therapeutics EPS Diluted (Quarterly) : -0.7989 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7989 |
| March 31, 2026 | -0.8121 |
| December 31, 2025 | -0.8263 |
| September 30, 2025 | -0.9196 |
| June 30, 2025 | -0.9761 |
| March 31, 2025 | -1.105 |
| December 31, 2024 | -1.266 |
| September 30, 2024 | -1.344 |
| June 30, 2024 | -1.516 |
| March 31, 2024 | -1.125 |
| December 31, 2023 | -1.461 |
| September 30, 2023 | -1.379 |
| June 30, 2023 | -1.402 |
| March 31, 2023 | -1.175 |
| December 31, 2022 | -1.396 |
| September 30, 2022 | -1.489 |
| June 30, 2022 | -1.328 |
| March 31, 2022 | -1.965 |
| December 31, 2021 | -1.092 |
| September 30, 2021 | -0.972 |
| June 30, 2021 | -1.009 |
| Date | Value |
|---|---|
| March 31, 2021 | -0.6878 |
| December 31, 2020 | -0.6882 |
| September 30, 2020 | -0.4738 |
| June 30, 2020 | -0.607 |
| March 31, 2020 | -0.6299 |
| December 31, 2019 | -0.573 |
| September 30, 2019 | -0.4868 |
| June 30, 2019 | -0.5606 |
| March 31, 2019 | -0.485 |
| December 31, 2018 | -0.4312 |
| September 30, 2018 | -0.53 |
| June 30, 2018 | -0.52 |
| March 31, 2018 | -0.51 |
| December 31, 2017 | -0.61 |
| September 30, 2017 | -0.44 |
| June 30, 2017 | -0.45 |
| March 31, 2017 | -0.36 |
| December 31, 2016 | -0.31 |
| September 30, 2016 | -0.22 |
| June 30, 2016 | -0.36 |
| March 31, 2016 | -9.89 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -1.176 |
| Twist Bioscience Corp. | -0.5617 |
| Prime Medicine, Inc. | -0.2376 |
| Moderna, Inc. | -1.965 |
| Q32 Bio, Inc. | -0.4398 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -106.63M |
| Revenue (Quarterly) | 7.659M |
| Total Expenses (Quarterly) | 114.29M |
| Enterprise Value | 1.352B |
| Gross Profit Margin (Quarterly) | 72.58% |
| Profit Margin (Quarterly) | -1.39K% |
| Earnings Yield | -27.38% |
| Normalized Earnings Yield | -27.35 |